NYSE: ARXAccelerant Holdings Stock
$14.23+0.46 (+3.34%)
Updated Jul 24, 2026
ARX Price
$14.23
Fair Value Price
N/A
Market Cap
$3.11B
52 Week Low
$9.18
52 Week High
$30.94
P/E
-2.18x
P/B
4.48x
P/S
2.94x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.01B
Earnings
-$1.37B
Gross Margin
76.1%
Operating Margin
-132.25%
Profit Margin
-142.5%
Debt to Equity
11.38
Operating Cash Flow
$332M
Beta
-0.03
Next Earnings
Aug 27, 2026
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ARX's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +5.11% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important ARX news, forecast changes, insider trades & much more!
ARX News
Overview
Due Diligence Score
–
Industry Average (32)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ARX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ARX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ARX is poor value based on its book value relative to its share price (4.48x), compared to the US Insurance Brokers industry average (4.04x)
P/B vs Industry Valuation
ARX is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ARX due diligence checks available for Premium users.
Valuation
ARX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-2.18x
Industry
23.19x
Market
14.13x
ARX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
4.48x
Industry
4.04x
ARX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ARX's financial health
Profit margin
Revenue
$273.3M
Net Income
-$5.2M
Profit Margin
-1.9%
ARX's Earnings (EBIT) of -$1.33B... subscribe to Premium to read more.
Interest Coverage Financials
ARX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$8.6B
Liabilities
$7.9B
Debt to equity
11.38
ARX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$21.4M
Investing
-$211.6M
Financing
-$19.2M
ARX's operating cash flow ($331.90M)... subscribe to Premium to read more.
Debt Coverage Financials
ARX vs Insurance Stocks
Accelerant Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.